Recent Advances in Genomics - An in-depth Case Study
Genomics is a study within genetics that concerns the analysis and sequencing of an organism’s gen. The future of genomics is very promising and Occasions. These are briefly mentioned here and will Expanded into an oral presentation. Evaluation of scientific evidence to support valid and useful genetic tests and counseling. Monitoring the use of genetic tests and family health history Evaluation of population, and outcome in different families. Searching for valid and useful genetic tests and family use Health history tools to plan clinical practice, policy and design Create programs to detect people who are at risk for the disease Diagnoses, and suggests appropriate intervention. Insert Genomic information and clinical decisions in health records. Develop practical recommendations that evaluate the net Health benefits of genetic tests and family health information. Evaluation of the impact of genetic applications in the individual Family, local community and population.
The concept of genomics aims to understand the genome's architecture, which comprises the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. Genomics is meant to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. Genomics is a broad spectrum that includes functional genomics, structural genomics, comparative genomics, epigenomics (epigenetics), and pharmacogenomics. Factors such as growth in investments & funds for genomics, declining cost of sequencing procedures, increasing number of start-up companies, technological advancements in genomics are expected to boost the market growth over years. However, the growth of the market is restrained by various factors such as nonexistence of skilled professionals and high cost of equipment used in genomics.
Globally, the gene synthesis has set the benchmark with its innovations and dynamic results. The industry has attracted various global leaders to invest in gene synthesis. For instance, in November 2017, Bolt Threads raised US$123 million in Series D funding that was led by Ballie Gifford along with the others such as Formation above 8, Founders Fund, Fidelity Management, Research Company, and Temasek. Allen & Company LLC. Bolt Threads also announced in TechCrunch that it has added to the amount for the Series D round, to sum up, the amount of US$213 million.
Companies have also increased their research and development funds for the enhancement of gene synthesis. Additionally, in 2016, Twist Bioscience raised its revenue with US$ 61 million for the scale-up and commercial operation of the silicon chip-based high throughput low-cost gene synthesis platform.
Few of the companies which are involved in Genomics study
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Eurofins
- Qiagen
- Agilent Technologies
- BGI
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Danaher
- GE Healthcare.